Pharmaguy™’s Twitter Stream – Q1 2009

Pharmaguy™ is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News

A Drug By Any Other Name

In this 5-minute audio snippet Pharmaguy discusses the absurdity of Rx drug names.

The Annual Pharmaguy™ Pioneer Award

Rather than recognizing specific campaigns, the Pharmaguy™ Pioneer Award gives kudos to a pharmaceutical executive or team who has 'pioneered' in the use of social media or mobile for marketing, research, patient support, or corporate communications purposes.

Anne C. Beal, M.D., MPH: Sanofi’s Definition of Patient Centricity

In this 2-minute audio snippet, Anne C. Beal, M.D., MPH, Sanofi, talks about patient centricity and Sanofi's commitment to engaging patients and improving outcomes.

Pharmaguy™’s Twitter Stream – Q3 2013

Pharmaguy™ is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News

Alan Schwarz and Dr. Aaron Kesselheim: The Selling of ADHD and Ethics of Disease...

In this 1-minute audio snippet, Alan Schwarz, National Correspondent at The New York Times and Dr. Aaron Kesselheim, Assistant Professor of Medicine, Brigham and Women's Hospital, discuss the ethics of disease awareness ads -- specifically ADHD awareness ads -- that mention the benefits of a class of drugs without also mentioning the common risks.

Pharmaguy’s Twitter Stream – 2008

Pharmaguy is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News

Pharmaguy™’s Twitter Stream – Q3 2009

Pharmaguy™ is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News

The Forgotten eHealth Code of Ethics

Any research or effort designed to improve the quality of health information on the Internet must build upon the work already done by the creators of the international eHealth Code of Ethics, which is as relevant today as it was back in 2000.

Andrew Schorr: To Engage Patients Pharma Must Commit to the Long Haul

In this 3-minute audio snippet, Andrew Schorr, Founder and Host of PatientPower.info, notes that pharma agency accounts come and go, but patients are living with their conditions day in and day out. Pharma has to be careful, says Schorr, when approaching patients about how they view the commitment.
- Advertisement -